Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5288951
Max Phase: Preclinical
Molecular Formula: C60H76N14O13
Molecular Weight: 1201.35
Associated Items:
ID: ALA5288951
Max Phase: Preclinical
Molecular Formula: C60H76N14O13
Molecular Weight: 1201.35
Associated Items:
Canonical SMILES: CCCCC[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCCNC(=O)[C@H](NC(=O)c2ccc(NN)nc2)CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C60H76N14O13/c1-3-4-6-17-42(57(84)73-48(31-51(77)78)60(87)70-45(52(61)79)28-35-13-7-5-8-14-35)69-59(86)47(30-38-33-64-41-16-10-9-15-40(38)41)72-56(83)43-18-11-12-27-63-55(82)44(67-54(81)37-21-25-49(74-62)65-32-37)24-26-50(76)66-34(2)53(80)71-46(58(85)68-43)29-36-19-22-39(75)23-20-36/h5,7-10,13-16,19-23,25,32-34,42-48,64,75H,3-4,6,11-12,17-18,24,26-31,62H2,1-2H3,(H2,61,79)(H,63,82)(H,65,74)(H,66,76)(H,67,81)(H,68,85)(H,69,86)(H,70,87)(H,71,80)(H,72,83)(H,73,84)(H,77,78)/t34-,42+,43+,44+,45-,46-,47-,48-/m0/s1
Standard InChI Key: CAWKIUQLKQSRMD-GYFGTUTMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1201.35 | Molecular Weight (Monoisotopic): 1200.5716 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Askari Rizvi SF, Zhang H.. (2021) Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities., 221 [PMID:34022717] [10.1016/j.ejmech.2021.113538] |
Source(1):